Two teams of scientists published studies on Sunday showing that blood from young mice reverses aging in old mice, rejuvenating their muscles and brains. As ghoulish as the research may sound, experts said that it could lead to treatments for disorders like Alzheimer’s disease and heart disease.
Bladder cells can now be derived from umbilical cord blood cells (UBCs). This important breakthrough will lead the way in developing regenerative therapies for the treatment bladder defects that are common in children with Spina bifida or other congenital defects.
Fanconi’s anemia is an autosomal recessive disorder with symptoms that include bone marrow failure, a predisposition to neoplasia, high incidence of myelodysplasia, progressive pancytopenia as well as nonhematopoietic developmental anomalies. The transplantation of stem cells is the only treatment available for this condition. The best results are reported when the sample is derived from a matched brother or sister. If a matched sibling sample is not available an unrelated donor sample might be used but the results are inferior and have a high possibility of morbidity and mortality¹.
Future Health has successfully released another sample to one of the leading hospitals in the Middle East to treat Severe Combined Immunodeficiency. The transplantation was performed on the 20th of January to a baby boy, and all preliminary tests show that his condition is improving after the procedure.
Press Release: Future Health’s Tooth Stem Cell service provides access to a ‘treasure chest’ of stem cells Future Health launched the tooth stem cell service a number of years ago based on the premise that teeth contain valuable Mesenchymal Stem Cells (MSCs) that are readily accessible and easy to characterise. Because these MSCs have an immunophenotype that is comparable to those already utilised in clinical trials, both extracted and deciduous teeth are thought to be a valuable source of both autologous and allogeneic MSCs.
Future Health Biobank officially launched the release of their new Human Tissue Authority approved Lipo Stem Cells service at The British Association of Aesthetic Plastic Surgeons (BAAPS) 29th Annual Scientific Meeting in London last month.